M. Arshad Siddiqui

3.1k citations

86 papers · 2.4k indexed · h-index 27

Co-authors: Víctor E. Márquez Victor Snieckus Pamela Russ Joseph J. Barchi Harry Ford Clifford George Abdallah Ezzitouni Jianying Wang
Topics: HIV/AIDS drug development and treatment (25 papers)Biochemical and Molecular Research (16 papers)Chemical Synthesis and Analysis (16 papers)
Cited by: Physiology Organic Chemistry Virology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Journal of Molecular Biology
Partner nations: United States Canada United Kingdom

In The Last Decade

M. Arshad Siddiqui

84 papers receiving 2.3k citations

Peers

Countries citing papers authored by M. Arshad Siddiqui

Since Specialization

Citations

This map shows the geographic impact of M. Arshad Siddiqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arshad Siddiqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arshad Siddiqui more than expected).

Fields of papers citing papers by M. Arshad Siddiqui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arshad Siddiqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arshad Siddiqui. The network helps show where M. Arshad Siddiqui may publish in the future.

Co-authorship network of co-authors of M. Arshad Siddiqui

This figure shows the co-authorship network connecting the top 25 collaborators of M. Arshad Siddiqui. A scholar is included among the top collaborators of M. Arshad Siddiqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Arshad Siddiqui. M. Arshad Siddiqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two‐Dimensional Materials‐Based Heterogeneous Thermo‐Catalysis: Results, Challenges, and Outlook 2025 ·M. Arshad Siddiqui,Yilin Wang,John Texter,Yongqiang Yao,Zhengang Ke,Irfan Ali Soomro,Bin Dai,Zhenyu Sun	0
2	Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor 2013 ·Bioorganic & Medicinal Chemistry Letters ·Yongqi Deng,Gerald W. Shipps,Lianyun Zhao,M. Arshad Siddiqui,Janeta Popovici-Müller,(unknown),José S. Duca,Alan Hruza,Thierry Fischmann,Vincent Madison,Rumin Zhang,Charles McNemar,Todd Mayhood,Rosalinda Syto,(unknown),Paul T. Kirschmeier,Emma Lees,David Parry,William T. Windsor	17
3	Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Xiaohua Huang,Cliff C. Cheng,Thierry Fischmann,José S. Duca,Matthew Richards,(unknown),(unknown),Lianyun Zhao,M. Arshad Siddiqui,David Parry,Nicole R. Davis,Wolfgang Seghezzi,Derek Wiswell,Gerald W. Shipps	26
4	Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Zhaoyang Meng,(unknown),Andrew J. McRiner,(unknown),Lianyun Zhao,(unknown),Xingmin Zhang,Thierry Fischmann,Charles E. Whitehurst,M. Arshad Siddiqui	10
5	Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Hongbo Zeng,David Belanger,(unknown),Gerald W. Shipps,Hua Miao,(unknown),M. Arshad Siddiqui,Michael G. Malkowski,Yan Wang	29
6	SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-Agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics 2010 ·Molecular Cancer Therapeutics ·Andrea Basso,Ming Liu,Chaoyang Dai,Kimberly Gray,(unknown),Seema Tevar,Suining Lee,Lianzhu Liang,A. S. Ponery,Bohdan Yaremko,Elizabeth Smith,Huadong Tang,Payal R. Sheth,M. Arshad Siddiqui,Daniel J. Hicklin,Paul T. Kirschmeier	17
7	Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·David Belanger,Michael Williams,Patrick J. Curran,Amit Kumar Mandal,Zhaoyang Meng,Matthew P. Rainka,(unknown),Neng‐Yang Shih,M. Arshad Siddiqui,Ming Liu,Seema Tevar,Suining Lee,Lianzhu Liang,Kimberly Gray,Bohdan Yaremko,J. Shawn Jones,Elizabeth B. Smith,D. B. Prelusky,Andrea Basso	16
8	Using conformationally locked nucleosides to calibrate the anomeric effect: implications for glycosyl bond stability 2010 ·Tetrahedron ·Hyung Ryong Moon,M. Arshad Siddiqui,Guangyu Sun,Igor Filippov,(unknown),Yi‐Chien Lee,Kristie M. Adams,Joseph J. Barchi,Jeffrey R. Deschamps,Marc C. Nicklaus,James A. Kelley,Víctor E. Márquez	3
9	Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Lianyun Zhao,Yingxin Zhang,Chaoyang Dai,Timothy J. Guzi,Derek Wiswell,Wolfgang Seghezzi,David Parry,Thierry Fischmann,M. Arshad Siddiqui	34
10	Synthesis and Hybridization Properties of Modified Oligodeoxynucleotides Carrying Non‐Natural Bases 2009 ·Chemistry & Biodiversity ·Anna Aviñó,(unknown),(unknown),M. Arshad Siddiqui,Víctor E. Márquez,Ramón Eritja	4
11	The triphosphate of β-d-4′-C-ethynyl-2′,3′-dideoxycytidine is the preferred enantiomer substrate for HIV reverse transcriptase 2006 ·Bioorganic & Medicinal Chemistry ·M. Arshad Siddiqui,Víctor E. Márquez	4
12	Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residues 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Benoit Bachand,(unknown),Lorraine Leblond,P.D. Winocour,Jeremy J. Edmunds,John R. Rubin,M. Arshad Siddiqui	14
13	Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Benoit Bachand,(unknown),(unknown),Jeremy J. Edmunds,P.D. Winocour,Lorraine Leblond,M. Arshad Siddiqui	23
14	In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors 2000 ·Thrombosis Research ·Lorraine Leblond,Brigitte Grouix,(unknown),(unknown),M. Arshad Siddiqui,P.D. Winocour	7
15	The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1 1999 ·Bioorganic & Medicinal Chemistry Letters ·Wayne L. Cody,(unknown),Annette M. Doherty,Jeremy J. Edmunds,John X. He,Lakshmi Narasimhan,(unknown),Stephen T. Rapundalo,John R. Rubin,(unknown),(unknown),P.D. Winocour,M. Arshad Siddiqui	10
16	Conformationally Restricted Nucleosides. The Reaction of Adenosine Deaminase with Substrates Built on a Bicyclo[3.1.0]hexane Template 1999 ·Nucleosides and Nucleotides ·Víctor E. Márquez,Pamela Russ,(unknown),M. Arshad Siddiqui,(unknown),Clifford George,Marc C. Nicklaus,(unknown),Harry Ford	30
17	The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2 1999 ·Bioorganic & Medicinal Chemistry Letters ·Wayne L. Cody,Corinne E. Augelli‐Szafran,(unknown),(unknown),Annette M. Doherty,Jeremy J. Edmunds,John X. He,Lakshmi Narasimhan,(unknown),(unknown),Stephen T. Rapundalo,John R. Rubin,(unknown),Lorraine Leblond,P.D. Winocour,M. Arshad Siddiqui	3
18	Synthesis and structure-activity relationship of potent bicyclic lactam thrombin inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·Benoit Bachand,John DiMaio,M. Arshad Siddiqui	16
19	Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 Modifications 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Wayne L. Cody,John DiMaio,Annette M. Doherty,Jeremy J. Edmunds,John X. He,Debra R. Holland,(unknown),(unknown),Lakshmi Narasimhan,John R. Rubin,Stephen T. Rapundalo,M. Arshad Siddiqui,(unknown),(unknown),P.D. Winocour	18
20	Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Corinne E. Augelli‐Szafran,Benoit Bachand,(unknown),John DiMaio,Annette M. Doherty,Jeremy J. Edmunds,Lorraine Leblond,(unknown),Lakshmi Narasimhan,(unknown),John R. Rubin,(unknown),P.D. Winocour,M. Arshad Siddiqui	14

About M. Arshad Siddiqui

M. Arshad Siddiqui is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 86 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (25 papers), Biochemical and Molecular Research (16 papers) and Chemical Synthesis and Analysis (16 papers). The work is most often cited by research in Physiology (274 citations), Organic Chemistry (1.2k citations) and Virology (162 citations). M. Arshad Siddiqui has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Víctor E. Márquez, Victor Snieckus, Pamela Russ, Joseph J. Barchi, Harry Ford, Clifford George, Abdallah Ezzitouni, Jianying Wang, Richard W. Wagner and Mark D. Matteucci. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact